Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Torrey Pines Institute for Molecular Studies announced a strategic agreement with The Tri-Institutional Therapeutics Discovery Institute.
read more
Eurofins Scientific has signed an exclusive agreement with Tata Group to acquire Advinus Therapeutics.
read more
ClinicalStudyDataRequest.com (CSDR) has increased the number of trials available to more than 3,460.
read more
Debiopharm has been selected to receive a funding award from CARB-X to advance the development of its antibiotic Debio 1453, a FabI inhibitor specifically targeting N. gonorrhoeae.
read more
Cryoport announced Novartis has signed an agreement contracting Cryoport over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.
read more
TTP and New England Biolabs (NEB) announce that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers.
read more
Eurofins Scientific has signed an agreement to acquire DiscoverX.
read more
Evotec announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas.
read more
Baxter International announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company.
read more
Dr. Reddy’s Laboratories and CHD Bioscience announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy’s Phase III clinical trial candidate, DFA-02.
read more
Ginkgo Bioworks and Swissaustral announced a new partnership to design strains of microorganisms that will produce industrial enzymes at scale.
read more
Smithers Rapra announced the opening of its extractables and leachables lab located in Akron, Ohio at the Akron Global Business Accelerator.
read more
The Catalent Applied Drug Delivery Institute announced Jim Spavins has joined the Institute’s Advisory Board.
read more
More than one third of pharmaceutical industry professionals are not confident that they will meet serialization deadlines in the US and Europe, according to new industry research.
read more
CMC ICOS Biologics and Trellis Bioscience have entered into a manufacturing agreement for the process development and production of two of Trellis’ monoclonal antibodies.
read more